Press Releases

ELRIG and The Protein Society Announce Keynote Speakers for Protein Sciences in Drug Discovery 2026

• Prof Dame Carol Robinson (University of Oxford), Dr Andrew Doré (Isomorphic Labs) and Prof Paula Booth (King’s College London) to lead event taking place from 10–11 November at GSK Stevenage • Programme to focus on AI, machine learning and data-driven approaches across protein design, characterisation and therapeutic development

Global Congress on Nephrology and Kidney Health

Veeva DQS Cleans Data for More Than 1 Million Subjects Across Over 1,000 Studies

CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development

CellCarta today announced a strategic partnership with Waters Corporation creating a framework to jointly pursue companion diagnostic and next-generation flow cytometry opportunities with pharmaceutical and biotechnology companies.

Upperton Unveils New Brand Identity Reflecting Evolution into Specialist CDMO

Upperton has unveiled a new brand identity at CPHI Milan, marking a significant milestone in the company's evolution into a specialist, end-to-end contract development and manufacturing organisation (CDMO) focused on solving the challenges of molecule development across oral, nasal, pulmonary and parenteral dosage forms.

Industry Leading RBQM Event Returns for 2026

CluePoints sponsored RBQMLive 2026 will explore shift from adoption to operational maturity.

CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and Companion Diagnostic Programs Across Drug Development

CellCarta and Imagene AI today announced an expanded collaboration to provide a coordinated path for biopharma companies to validate, deploy, and scale AI-powered biomarker and companion diagnostic programs.

Advarra Launches Site Identification Technology with Insights Directly from Sites

Advarra today announced the launch of its new Site ID technology.

PumasAI Brings AI, Scientific Machine Learning and Advanced Pharmacometric Research to ACoP 2026

Pre-conference workshop on the future of AI in pharmacometrics and four scientific poster presentations highlight PumasAI’s presence at the American Conference on Pharmacometrics (ACoP)

Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth

Three new commercial appointments for Symbiosis to drive international growth

Ceryx Medical appoints Professor Zaheer Yousef OBE as Chief Medical Officer

Ceryx Medical has appointed Professor Zaheer Yousef OBE as Chief Medical Officer. Professor Yousef is a consultant cardiologist at the University Hospital of Wales and was principal investigator on RSA-Pace, Ceryx's multi-centre study of its respiratory sinus arrhythmia pacing technology. He joins as the company moves towards a clinical study designed to demonstrate the full clinical benefit of its implantable device in people living with heart failure.

Biopharma PEG Expands Functionalized PEG Linker Portfolio for Bioconjugation Research

Biopharma PEG expands its portfolio of functionalized PEG linkers for bioconjugation and pharmaceutical research, including azide, alkyne, DBCO, and BCN PEG derivatives, alongside monodispersed, polydispersed, and custom PEG solutions.

Huateng Pharma to Showcase High-Purity PEG Products and CDMO Capabilities at CPHI Milan 2026

Hunan Huateng Pharmaceutical Co., Ltd. will exhibit at CPHI Milan 2026, Booth 3H94, showcasing high-purity PEG products, pharmaceutical intermediates, APIs, and CDMO capabilities. The company supports pharmaceutical and biopharmaceutical projects from research and process development through manufacturing.

Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline

The University of Turin Adopts Openwater’s Open-Motion Device to Study Muscle Blood Flow and Vascular Responses

Researchers in the University’s Integrative Physiology Lab will evaluate Openwater’s wearable platform for studying muscle blood-flow dynamics and vascular responses to nervous system activity, with potential future applications in noninvasive neural communication

Systech Launches New All-in-One Pharma Packaging and Serialization Stations

Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth

Sygnature Discovery establishes DEL screening collaboration with X-Chem

Johnson County ClinTrials (JCCT) Rebrands as Sequoia Clinical Research

New identity unites three site organizations under one banner as company expands beyond its vaccine-trial roots into multi-therapeutic clinical research site network